ߜ Jugular bulb oxygen monitoring can be used to estimate the adequacy of cerebral blood flow to support cerebral metabolism after severe head injury. In the present study, the authors studied the cerebral arteriovenous oxygen difference (AVDO 2 ) before and after treatment in 32 head-injured patients (Glasgow Coma Scale scores ≤ 8) to examine the relationships among AVDO 2 and cerebral perfusion pressure (CPP), delayed cerebral infarction, and outcome. Fifteen patients (Group A) underwent craniotomy for hematoma evacuation and 17 (Group B) received mannitol for sustained intracranial hypertension (intracranial pressure Ͼ 20 mm Hg, Ͼ 10 minutes). Radiographic evidence of delayed cerebral infarction was observed in 14 patients. Overall, 17 patients died or were severely disabled. Cerebral AVDO 2 was elevated before craniotomy or mannitol administration; the mean AVDO 2 for all patients before treatment was 8.6 Ϯ 1.8 vol%. Following craniotomy or mannitol administration, the AVDO 2 decreased in 27 patients and increased in five patients (mean AVDO 
Clinical Material and Methods

Patient Population
During a 12-month period, 32 patients with severe traumatic brain injury (postresuscitation Glasgow Coma Scale 51 [GCS] scores of ≤ 8) admitted to our institution within 8 hours of injury were prospectively evaluated. There were 21 males and 11 females in the group, ranging in age from 14 to 79 years (median 34.5 years). The patients fulfilled the following criteria: 1) isolated nonpenetrating head injury; 2) normal blood pressure; 3) normothermia; 4) hematocrit above 30%; and 5) survival more than 24 hours after admission. Two groups were identified: Group A (15 patients) underwent craniotomy for evacuation of a traumatic mass lesion and Group B (17 patients) demonstrated no mass lesion on a CT scan but received a mannitol infusion for sustained intracranial hypertension (ICP Ͼ 20 mm Hg, Ͼ 10 minutes) despite adequate sedation and ventilation.
Case Management
All patients were managed according to a standard protocol that emphasized prompt evacuation of intracranial mass lesions and prevention of secondary cerebral insults. Patients suffering severe head injury were initially evaluated and aggressively resuscitated, including intubation and mechanical ventilation, by paramedics in the field. On admission to the emergency department, the patients were hemodynamically stabilized and, after initial evaluation, all underwent cranial CT scanning. Patients with surgical mass lesions were taken directly to the operating room for hematoma evacuation. All patients were admitted to the neurosurgical intensive care unit and their cases were managed according to a standard protocol designed to prevent secondary insults. This protocol included: 1) intubation and mechanical ventilation to maintain PaO 2 at above 100 mm Hg and PaCO 2 at 30 to 35 mm Hg; 2) volume replacement with albumin and crystalloid boluses to maintain systolic blood pressure at more than 100 mm Hg and central venous pressure between 5 cm and 10 cm H 2 O; 3) maintenance of normal serum glucose and electrolyte levels and a hematocrit of between 30% and 40%; and 4) treatment of increased ICP (Ͼ 20 mm Hg) in the following sequence: sedation (morphine sulfate), muscle paralysis (pancuronium therapy), head elevation (10-30˚), and moderate hyperventilation (PaCO 2 maintained at 25-30 mm Hg). If a patient's ICP remained elevated (Ͼ 20 mm Hg, Ͼ 10 minutes) despite these measures, an intravenous bolus of 20% mannitol was administered over 10 to 15 minutes (0.5-1 g/kg).
Physiological Measurements
The following physiological parameters were continuously monitored: arterial blood pressure through a radial arterial catheter; arterial oxygen saturation (SaO 2 ) by pulse oximetry; end-tidal CO 2 using a capnometer installed through the endotracheal tube; temperature measured through an esophageal temperature probe in the operating room or by tympanic thermometer in the intensive care unit; and ICP through a fiberoptic parenchymal intracranial pressure monitor (Camino Laboratories, San Diego, CA). The level of cerebral perfusion was calculated as the difference between the mean arterial blood pressure (MABP) and ICP (CPP = MABP Ϫ ICP). All parameters were recorded in a computerized database and were correlated with the AVDO 2 measurements.
Determination of Cerebral Arteriovenous Oxygen Difference
To measure jugular venous oxygen saturation (SjVO 2 ), a 5.5-in-long 16-gauge catheter was inserted percutaneously into the internal jugular vein. 22 The catheter tip, confirmed by x-ray film, was positioned in the jugular bulb. The catheter was placed on the side of the mass lesion to be evacuated or, in Group B patients, in the dominant jugular vein based on a CT assessment of the jugular foramen. 12 The ICP monitor was placed ipsilateral to the jugular catheter. Arterial (radial) and retrograde jugular venous samples were obtained simultaneously: 1) at skin incision and skin closure in patients undergoing craniotomy and 2) before and 30 minutes after completing intravenous mannitol administration. The samples were used to determine pH, PaO 
Diagnosis of Delayed Cerebral Infarction
Cranial CT scans (model GE 9800; General Electric Medical Systems, Milwaukee, WI) were obtained in all patients at admission, shortly after surgery or mannitol infusion (1-2 hours), on a daily basis for 3 days, and 1 week after admission. A low attenuation region conforming to a vascular territory identified on CT scanning was regarded as radiographic evidence of delayed infarction if an area of hypoperfusion in the same region was identified on a nuclear medicine single-photon emission CT scan obtained using ( Fig. 1) . Additional criteria for distinguishing an infarcted area from edema were the restriction of the hypodense area to a vascular territory, distinct margins, and persistence beyond the acute injury phase. Isolated low attenuation abnormalities in the posterior cerebral artery distribution were regarded as evidence of herniation and not of infarction.
Patient Outcome
Outcome was assessed 6 months after head injury, by means of a clinic visit or telephone interview, according to the Glasgow Outcome Scale 23 (GOS). Patients with a GOS score of "good" or "moderately disabled" are independent for all their needs and participate in a normal social life; for statistical comparison, these patients were classified as having a favorable outcome. Unfavorable outcome was assigned to those patients who died or were not capable of an independent existence.
Statistical Analysis
Data are expressed as the mean Ϯ standard deviation or, in situations in which samples depart substantially from normal distributions, they are summarized as the median. A two-sample significance of data that departed from a normal distribution was tested using the Mann-Whitney U-test. Student's t-test was used to assess differences between groups when the samples were normally distributed. When appropriate, Pearson's chi-square test was used to test for sample differences on categorical variables. Fisher's exact test was substituted when one or more cells had expected frequencies less than five. Simple regression analysis or Pearson's correlation was used to relate continuous variables to one another. In the case of multiple associations, Bonferronian inequality was used. Statistical significance is assumed for comparisons in which probability is less than 0.01. All statistical analyses were performed using a commercially available software package (StatView II, 1987; Abacus Concepts, Berkeley, CA).
Results
Patient Characteristics
The clinical characteristics of the patients are summarized in Table 1 . The majority of patients (25) were injured in motor vehicle accidents; four patients were injured in a fall, and three suffered blunt trauma. Fifteen patients underwent craniotomy for mass lesions (Group A), whereas 17 patients received intravenous administration of mannitol for elevated ICP (Group B). Overall, the mean ICP following craniotomy or mannitol administration was 17.8 Ϯ 7.8 mm Hg ( Table 1 ). The CPP was greater than 70 mm Hg in 27 patients, between 60 and 70 mm Hg in four Group B patients, and less than 60 mm Hg in one Group B patient. The mean CPP was greater in Group A than Group B patients; overall, the mean posttreatment CPP was 75 Ϯ 9.8 mm Hg (Table 1) .
Cerebral Arteriovenous Oxygen Difference
Cerebral AVDO 
Delayed Cerebral Infarction and Arteriovenous Oxygen Difference
Radiographic evidence of delayed cerebral infarction was identified in six Group A patients and eight Group B patients. The relationship between AVDO 2 and delayed cerebral infarction is illustrated in Fig. 2 . The mean AVDO 2 before craniotomy or mannitol infusion was similar in patients who subsequently did or did not develop radiographic evidence of delayed cerebral infarction. By contrast, after treatment both an elevated AVDO 
Outcome and Arteriovenous Oxygen Difference
Outcome was assessed at 6 months: 13 patients had and outcome is summarized in Fig.  3 . Whereas the AVDO The association between delayed infarction or outcome and age, admission GCS score, ICP, or CPP was examined using bivariate analysis; the results are listed in Tables  2 and 3 . Advanced age was significantly associated with delayed cerebral infarction (p = 0.002) and older patients undergoing craniotomy were more likely to experience an unfavorable outcome (p = 0.004). The admission GCS score did not predict delayed cerebral infarction, but a low admission GCS score was associated with unfavorable outcome (p = 0.006). In patients treated with mannitol there was a significant association between elevated posttreatment, but not pretreatment, ICP and delayed cerebral infarction (p = 0.004). An association between CPP and delayed infarction or outcome was not observed.
Discussion
In the present report we describe our experience using jugular bulb monitoring in 32 severely head injured patients. The results demonstrate that AVDO 2 is elevated in patients suffering traumatic mass lesions or intracranial hypertension. When measured before craniotomy or mannitol administration, the AVDO 2 was not predictive of delayed cerebral infarction or outcome. By contrast, limited improvement in an elevated AVDO 2 after either craniotomy or mannitol administration was significantly associated with both delayed cerebral infarction and unfavorable outcome. In addition, a relationship between CPP and AVDO 2 was not observed. These findings emphasize the complex pathophysiology leading to delayed cerebral infarction and the need for repeated or continuous observations in patients suffering severe traumatic brain injury.
Methodological Considerations
There are several important points to bear in mind when interpreting jugular bulb oxygen monitoring results. First, focusing on blood samples from one jugular bulb may lead one to overlook ischemia or infarction in the other hemisphere because differences in oxygen saturation between the two hemispheres can occur. These differences, however, are of potential clinical significance in individuals with unilateral lesions. 15, 16, 47, 48 The likelihood of missing contralateral abnormalities was reduced in this study by placing the catheter ipsilateral to mass lesions because experimental and clinical studies demonstrate that ischemia is generally identified adjacent to traumatic lesions. 25, 30, 45 In Group B patients (who had no mass lesion) the catheter was placed on the dominant side of jugular flow, usually the right side, by evaluating the size of the jugular foramen on CT scanning. 12 The ICP monitor was placed ipsilateral to the jugular catheter. Second, AVDO 2 samples may lead one to miss regional ischemia. We cannot rule out this possibility but we believe that it is unlikely because radiographic evidence of infarction, which always correlated with a defined vascular territory, was only observed in patients in our study whose posttreatment AVDO 2 was greater than 6 vol%. By contrast, when posttreatment AVDO 2 was less than 6 vol%, no evidence for cerebral infarction was observed. Third, extracerebral contamination may be associated with sample withdrawal, particularly when CBF is low. Dye injection studies, however, demonstrate that jugular bulb samples contain insignificant amounts of extracerebral blood, provided the catheter is within the jugular bulb. 47 We were careful, therefore, to obtain radiographic confirmation of the catheter position in all patients. Finally, there is the question as to whether venous obstruction in the neck can elevate ICP. We think this problem is unlikely because we did not observe an ICP increase during catheter insertion. Studies by Goetting and Preston 17 have similarly demonstrated no evidence of jugular vein obstruction that is sufficient to elevate ICP in the catheterized vessel. Bearing these caveats in mind, when used carefully, jugular bulb oxygen saturation monitoring may provide a reliable estimate of cerebral oxygenation.
Arteriovenous Oxygen Difference and Cerebral Ischemia
Our results demonstrate that before treatment an elevated AVDO because the cerebral metabolic rate of oxygen decreases when tissue dies. 37, 43 In patients with cerebral infarction, knowledge of cerebral lactate may be useful; 42 however, the compensated but hypoperfused state is important to recognize because the deleterious effects of ischemia and hypoxia may still be ameliorated.
Cerebral Perfusion Pressure and Cerebral Infarction
We did not observe a correlation between AVDO 2 and CPP, whereas a relationship between ICP and AVDO 2 was observed. Experimental studies using magnetic resonance spectroscopy have demonstrated that ICP and AVDO 2 correlate with brain energy failure, as identified by changes in phosphocreatine. By contrast, brain energy failure occurs over a wide range of CPPs. 49, 50 Similarly, clinical studies have demonstrated that baseline CBF values may not correlate with CPP or ICP. 30 Other studies, however, have demonstrated a significant linear correlation among CPP (but not ICP) and SjVO 2 and AVDO 2 , provided the CPP is less than 70 mm Hg. 7, 8 The majority of patients in our series, however, demonstrated CPPs greater than 70 mm Hg, which in part may explain the poor correlation between AVDO 2 and CPP. It is also conceivable that increased ICP may reflect the irreversible end result of biochemical and cellular events, rather than act as the cause of neuron damage, and thus may demonstrate a relationship with AVDO 2 . An important finding in this series was the radiographic evidence of delayed cerebral infarction despite an adequate CPP. This finding is consistent with experimental studies in which an ischemic zone has been shown adjacent to subdural hematomas in rats with an adequate CPP. 32 Therapies based on CPP maintenance 44 or determination of an ideal CPP by calculation of a transcranial Doppler pulsatility index and SjVO 2 for individual patients 7, 8 have been demonstrated to be feasible management strategies for head-injured patients. We believe that an adequate CPP is important in head injury management. However, our results indicate that an adequate CPP alone is insufficient to prevent cerebral infarction in all patients. The progression to infarction despite adequate CPP may be explained by altered autoregulation, direct toxicity from blood, or neurochemical alterations. For example, experimental models of traumatic hematoma 6 or diffuse axonal injury 13 and clinical studies 1 demonstrate that levels of excitatory amino acids, such as glutamate, which in high concentrations appear integral to the pathophysiological mechanism of neuron injury and death in cerebral ischemia, 27 are increased after head injury and may alter membrane permeability through activation of ligandgated channels. Similarly, following injury, direct mechanical stimulation can cause ionic fluxes and neuron firing. This ionic destabilization places enormous energy demands on the cells to activate pumping mechanisms to restore the ionic balance in the first few hours after trauma. 20 Microdialysis studies in head-injured patients demonstrate elevated glutamate levels during episodes of jugular oxygen desaturation. 41 Whether the failure of AVDO 2 to improve after treatment reflects a continued demand for oxygen to restore membrane stability affected by sustained excitotoxicity or mechanical disruption is not clear from our study. However, the failure of AVDO 2 to improve after treatment does define a subgroup of patients who, after treatment, can progress to cerebral infarction despite adequate CPP.
Arteriovenous Oxygen Difference and Outcome
The results in this series demonstrate that a limited improvement in elevated AVDO 2 following craniotomy or mannitol administration is associated with an unfavorable outcome and supports a role for AVDO 2 monitoring as a predictive tool in head injury. By contrast, posttreatment ICP and CPP in this group of severely head injured patients were not reliable outcome predictors. Several investigators using continuous jugular oxygen monitors have observed a significant association between episodes of jugular oxygen desaturation and poor outcome following head injury. 10, 11, 40, 41, 46 For example, Robertson, et al., 41 observed a 21% mortality rate in patients with no desaturation, 37% after a single episode, and 69% after multiple episodes. Poor outcome may also be associated with a reduced AVDO 2 , 21,40 because cerebral metabolism is significantly depressed once cerebral infarction has occurred.
Outcome after head injury depends on many variables; although not conclusive, the observations in this report lead us to suggest that posttreatment levels of AVDO 2 may provide reliable and, perhaps, independent outcome prediction. In other studies evaluating continuous jugular oxygen saturation after head injury, multivariate analysis has indicated that after adjustment for outcome determinants such as age, ICP, and GCS score, the number of desaturations continues to demonstrate a significant association with outcome: one episode of desaturation doubled the risk of a poor outcome, whereas multiple desaturations were associated with a 14-fold increase in the risk of poor outcome. 18 Whether the predictive information provided by AVDO 2 monitoring is a useful management tool is not addressed in this study. The ability to predict outcome, however, is important because when outcome can be accurately predicted, management can be directed at potentially avoidable deleterious factors. In addition, physiological categorization, based on AVDO 2 values, of patients at risk for delayed cerebral infarction before CT evidence for ischemia is observed, may help distinguish different causes of intracranial hypertension or cerebral ischemia early in the patient's clinical course when specific targeted therapies are ideally started. 46 Unfortunately, jugular saturation monitors require frequent recalibration and a high percentage of readings are erroneous because of catheter movement, displacement, intimal impaction, or clot formation. 14, 46 Despite these limitations, jugular saturation monitoring can help guide therapy, optimize CPP, and measure the effects of therapeutic interventions, such as ventilation or mannitol administration, to ensure adequate CBF to meet metabolic demands. 8, 10, 11, 35, 49 Jugular saturation monitors may also detect transient episodes of cerebral hypoxia from potentially preventable systemic causes such as hypotension, hypoxia, fever, or seizures. 11, 18, 40 The identification of inadequate cerebral oxygenation is important in the management of cases of head injury. The validity of using CPP as a measure of cerebral oxygenation becomes limited when autoregulatory mechanisms are disturbed and it also leads one to ignore other potential causes of cerebral ischemia after head injury. Results obtained in cerebral blood flow studies are disappointing in identifying which patient is at risk for ischemia because reduced, normal, and increased flow can be associated with a poor outcome. 5, 28, 30, 34, [36] [37] [38] [39] [40] These discrepancies may result, in part, from methodological differences. However, quantification of CBF alone cannot define the relationship between oxygen supply and consumption because the adequacy of oxygenation is also determined by variables such as autoregulation, CO 2 reactivity, and coupling of CBF and cerebral metabolism that are disturbed in a significant number of head-injured patients. 2, 3, 9, 14, 26, 34, 36 Furthermore, confounding variables such as vasospasm, anemia, hypoxia, and seizures may reduce the oxygen carrying capacity. A measure of the balance between cerebral oxygen delivery and consumption, such as AVDO 2 , may therefore be useful and, when combined with multimodality monitoring, may provide a reasonable means to identify patients in which secondary ischemic damage can be ameliorated by therapeutic intervention directed at its pathophysiological mechanism.
Applications for Jugular Oxygen Monitoring
